Literature DB >> 19598221

Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.

Amy Y Chen1, Ahmedin Jemal, Elizabeth M Ward.   

Abstract

BACKGROUND: Studies have reported an increasing incidence of thyroid cancer since 1980. One possible explanation for this trend is increased detection through more widespread and aggressive use of ultrasound and image-guided biopsy. Increases resulting from increased detection are most likely to involve small primary tumors rather than larger tumors, which often present as palpable thyroid masses. The objective of the current study was to investigate the trends in increasing incidence of differentiated (papillary and follicular) thyroid cancer by size, age, race, and sex.
METHODS: Cases of differentiated thyroid cancer (1988-2005) were analyzed using the National Cancer Institute's Surveillance Epidemiology and End Results (SEER) dataset. Trends in incidence rates of papillary and follicular cancer, race, age, sex, primary tumor size (<1.0 cm, 1.0-2.9 cm, 3.0-3.9 cm, and >4 cm), and SEER stage (localized, regional, distant) were analyzed using joinpoint regression and reported as the annual percentage change (APC).
RESULTS: Incidence rates increased for all sizes of tumors. Among men and women of all ages, the highest rate of increase was for primary tumors <1.0 cm among men (1997-2005: APC, 9.9) and women (1988-2005: APC, 8.6). Trends were similar between whites and blacks. Significant increases also were observed for tumors > or =4 cm among men (1988-2005: APC, 3.7) and women (1988-2005: APC, 5.70) and for distant SEER stage disease among men (APC, 3.7) and women (APC, 2.3).
CONCLUSIONS: The incidence rates of differentiated thyroid cancers of all sizes increased between 1988 and 2005 in both men and women. The increased incidence across all tumor sizes suggested that increased diagnostic scrutiny is not the sole explanation. Other explanations, including environmental influences and molecular pathways, should be investigated.

Entities:  

Mesh:

Year:  2009        PMID: 19598221     DOI: 10.1002/cncr.24416

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  349 in total

1.  Macrometastasis in Papillary Thyroid Cancer Patients is Associated with Higher Recurrence in Lateral Neck Nodes.

Authors:  Soo Young Kim; Bup-Woo Kim; Ju Yeon Pyo; Soon Won Hong; Hang-Seok Chang; Cheong Soo Park
Journal:  World J Surg       Date:  2018-01       Impact factor: 3.352

2.  Cancer-related worry in Canadian thyroid cancer survivors.

Authors:  Lauren Bresner; Rita Banach; Gary Rodin; Lehana Thabane; Shereen Ezzat; Anna M Sawka
Journal:  J Clin Endocrinol Metab       Date:  2014-11-13       Impact factor: 5.958

3.  Levothyroxine absorption in morbidly obese patients before and after Roux-En-Y gastric bypass (RYGB) surgery.

Authors:  Ileana Gabriela Sanchez Rubio; Ana Luiza Galrão; Marco Aurelio Santo; Antonio Carlos Zanini; Geraldo Medeiros-Neto
Journal:  Obes Surg       Date:  2012-02       Impact factor: 4.129

4.  Increasing incidence of thyroid cancer in Great Britain, 1976-2005: age-period-cohort analysis.

Authors:  Richard J Q McNally; Karen Blakey; Peter W James; Basilio Gomez Pozo; Nermine O Basta; Juliet Hale
Journal:  Eur J Epidemiol       Date:  2012-07-04       Impact factor: 8.082

Review 5.  Exposing the thyroid to radiation: a review of its current extent, risks, and implications.

Authors:  Bridget Sinnott; Elaine Ron; Arthur B Schneider
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

6.  Increasing incidence of differentiated thyroid cancer in South East England: 1987-2006.

Authors:  Oladejo Olaleye; Udeme Ekrikpo; Ram Moorthy; Owen Lyne; Jill Wiseberg; Myles Black; David Mitchell
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-11-12       Impact factor: 2.503

Review 7.  Thyroid and parathyroid surgery in pregnancy.

Authors:  Randall P Owen; Katherine J Chou; Carl E Silver; Yaakov Beilin; Jian J Tang; Robert T Yanagisawa; Alessandra Rinaldo; Ashok R Shaha; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-28       Impact factor: 2.503

Review 8.  New insights in risk stratification of differentiated thyroid cancer.

Authors:  Maria Papaleontiou; Megan R Haymart
Journal:  Curr Opin Oncol       Date:  2014-01       Impact factor: 3.645

9.  lncRNA BANCR promotes EMT in PTC via the Raf/MEK/ERK signaling pathway.

Authors:  Yuanyuan Wang; Jiaojiao Gu; Xiangde Lin; Wei Yan; Wenchao Yang; Guoyang Wu
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

10.  Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer.

Authors:  Min Zhou; Yunyun Chen; Makoto Adachi; Xiaoxia Wen; Bill Erwin; Osama Mawlawi; Stephen Y Lai; Chun Li
Journal:  Biomaterials       Date:  2015-04-24       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.